| Ranbaxy oesophagitis drug gets USFDA nod |
| BS Reporter / New Delhi February 7, 2008 |
| Ranbaxy Laboratories, generic drug manufacturer, today said it has received tentative approval from the US Food and Drug Administration (USFDA) for Esomeprazole Magnesium Delayed-Release Capsules, 20 mg (base) and 40 mg (base). Nexium (Esomeprazole) is the second largest selling drug in USA with total annual market sales of $5.5 billion (IMS |
